Lord, Abbett & Co’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-54,555
Closed -$436K 595
2023
Q1
$436K Sell
54,555
-453,293
-89% -$4.66M ﹤0.01% 528
2022
Q4
$5.77M Sell
507,848
-235,442
-32% -$2.57M 0.02% 482
2022
Q3
$6.49M Hold
743,290
0.02% 449
2022
Q2
$7.4M Sell
743,290
-44,300
-6% -$446K 0.03% 441
2022
Q1
$7.92M Sell
787,590
-85,296
-10% -$907K 0.02% 493
2021
Q4
$11.1M Buy
872,886
+7,200
+0.8% +$93.8K 0.03% 472
2021
Q3
$10.8M Sell
865,686
-3,200
-0.4% -$43.4K 0.03% 520
2021
Q2
$13.1M Buy
868,886
+252,900
+41% +$3.8M 0.03% 490
2021
Q1
$8.46M Buy
615,986
+34,200
+6% +$530K 0.02% 552
2020
Q4
$10.6M Buy
+581,786
New +$8.98M 0.03% 510

Other funds holding PTVE

Lord, Abbett & Co's PTVE Position: Q2 2023 in Review

Lord, Abbett & Co sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2023, closing a stake of 54,555 shares — an estimated $436K sold.

Lord, Abbett & Co first reported a position in PTVE in Q4 2020 and held it in 10 quarters. The position peaked at $13.1M in Q2 2021. 122 funds tracked by Wall St. Rank hold PTVE as of Q2 2023.

  • Lord, Abbett & Co reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 54,555 Pactiv Evergreen Inc. Common stock shares in Q2 2023, an estimated $436K.
  • Lord, Abbett & Co first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 10 quarters.
  • Lord, Abbett & Co's Pactiv Evergreen Inc. Common stock position peaked at $13.1M in Q2 2021.
  • 122 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2023.

Based on Lord, Abbett & Co's 13F filing for Q2 2023, filed 14 Aug 2023.